Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088101
Status:
COMPLETED
Last Update Posted:
2008-12-04
First Post:
2004-07-20
Brief Title:
STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors
Sponsor:
Synta Pharmaceuticals Corp
Organization:
Synta Pharmaceuticals Corp
Organization Data
Organization:
Synta Pharmaceuticals Corp
Class:
INDUSTRY
Study ID:
5312-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Synta Pharmaceuticals Corp
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None